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Summary and Implications 
Injectable supplementation of trace minerals is often 
used to combat the malabsorption of microminerals due to 
antagonists in feed and water. Previous research has shown 
that Multimin90, a commercial supplement containing 
copper, zinc, manganese, and selenium, has been shown to 
have a positive impact on reproductive efficiency and 
pregnancy rates in beef cattle. The objective of this study 
was to determine the effects of supplementation of 
MultiMin90 on embryo quality in superovulated heifers. 
This report includes the preliminary results of the first year 
of an ongoing study.  Though there was no difference in 
overall embryo quality, supplementation of MultiMin90 
tended to reduce the proportion of nonfertilized embryos per 
flush and resulted in one more embryo per flush when 
compared to a saline-treated control.  
Introduction 
 MultiMin90 is an injectable trace mineral supplement 
that contains 15 mg copper/mL, 60 mg zinc/mL, 10 mg 
manganese/mL, and 5 mg selenium/mL. Recently, this 
supplement has been shown to have a positive impact on 
reproductive efficiency and pregnancy rates in beef cattle.  
In cattle, a deficiency of trace minerals can result in 
irregular or suppressed estrus cycles, reduced pregnancy 
rates, and difficulties during parturition. Moreover, as a 
combined injection, these minerals have been shown to 
increase conception rates and provide benefit to the immune 
system. Improved pregnancy rates could be accomplished 
through a number of avenues, including reduced embryonic 
loss, altered hormone production or clearance, decreased 
pregnancy losses, or improved embryo quality, though the 
exact pathway is still unclear.  
The objective of this study was to determine how the 
supplementation of this product impacts embryo quality. 
This was accomplished by using superovulation and embryo 
flushing to study embryo development and quality. It was 
hypothesized that MultiMin90 would improve quality of 
embryos recovered from ovarian superstimulated donor 
heifers seven days post-artificial insemination (AI). 
 
Materials and Methods 
Eighteen non-pregnant, yearling dairy heifers from the 
Iowa State University Dairy Farm were used for this study. 
The heifers received a common diet that met or exceeded 
NRC requirements. Each heifer was randomly assigned to 
receive an injection of saline (CON) or MultiMin90 (MM) 
per label dose (1 mL/100 pounds of body weight), with a 
total nine receiving treatment and nine as controls.  
Heifers were treated and superovulated in pairs, for a 
total of nine reps. On day 0 of each rep, heifers were given a 
Controlled Internal Drug Release (CIDR) device and 
concurrently administered either their CON or MM 
treatment. This was paired with an industry standard, 17-day 
superstimulation protocol with GnRH, PGF2α, and 
decreasing doses of FSH administered twice daily (Figure 
1). Heifers were artificially inseminated on the evening of 
day 10 and morning of day 11 approximately 12 hours apart. 
An additional dose of GnRH was given concurrently with 
the first AI. 
Embryos were recovered on day 17 (7 days after 
artificial insemination) via non-surgical uterine flush. 
Embryos were evaluated according to International Embryo 
Transfer Society standards. Each embryo was given a 
developmental stage (Table 1) and quality grade (Table 2). 
Data were analyzed using the MIXED procedures of 
SAS with animal as the experimental unit. P-values ≤ 0.05 
were considered to be significant; whereas 0.06 < P ≤ 0.15 
were considered a tendency. One heifer of the CON 
treatment did not respond to the superstimulation protocol 









Iowa State University Animal Industry Report 2017 
 
Results and Discussion 
There was no effect of the treatment on total number of 
embryos, number of transferrable embryos, or number of 
freezable embryos (P ≥ 0.21; Table 3). On average, the 
proportion of nonfertilized embryos per flush tended to be 
greater in CON heifers than in MM heifers (P = 0.15; Table 
4). MM heifers tended to have an increase in the number of 
Quality 2 (P = 0.08) and Quality 3 (P = 0.15) embryos 
compared to the CON heifers (Table 4). Though MM did 
not impact embryo quality, these data suggest that MM does 
increase the average proportion of viable embryos per flush 
due to the lower average proportion of nonfertilized 
embryos. 
MM tended to increase the number of Stage 4 embryos 
(P = 0.09; Table 5). Moreover, on average, the proportion of 
Stage 4 (P = 0.11) and Stage 5 (P = 0.11) embryos per flush 
tended to be greater in the MM heifers. It might be 
suggested that such trends indicate a more synchronous 
ovulation and embryo development pattern. 
In conclusion, these preliminary data indicate that while 
MM treatment does decrease the average proportion of 
nonfertilized embryos, there is not a significant trend 
towards increased embryo quality overall. Although not 
statistically significant, the numerical increase in 
transferrable embryos likely has economic benefit for the 
producer. Additional replications of this work are planned 
for the coming year. 
Table 1. International Embryo Transfer Society 
standards for embryo staging. 
Stage Characteristics 
1 Unfertilized 
2 2—12 cell mass 
3 Early morula 
4 Morula 
5 Early blastocyst 
6 Blastocyst 
7 Expanded blastocyst 
8 Hatched blastocyst 




Table 2. International Embryo Transfer Society standards for embryo quality 
grade. 
Quality Grade Characteristics 
1: Excellent or Good Uniform, spherical in 
appearance. Minor irregularities 
in structure. At least 85% of cell 
mass intact and viable. 
2: Fair Moderate irregularities in 
structure. At least 50% of cell 
mass intact and viable. 
3: Poor Many irregularities in structure. 
At least 25% of cell mass intact 
and viable. 
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Table 3. Effects of an injectable trace mineral supplement at initiation of superovulation protocol 
on embryo production in yearling dairy heifers. 
Total Embryos Con1 MM2 SEM3 P-value 
Total 
Embryos, no. 
4.78 6.00 1.28 0.51 
Transferrable 
Embryos, no. 
2.44 4.13 0.88 0.21 
Freezable 
Embryos, no. 
2.44 3.88 0.92 0.30 
1Control (Saline) 
2 Multimin90 containing 60 mg/mL Zn, 10 mg/mL Mn, 5 mg/mL Se, and 15 mg/mL Cu 
3 n = 9 for MM; n = 8 for CON  
 
 
Table 4. Effects of an injectable trace mineral supplement at initiation of superovulation protocol on embryo quality in 
yearling dairy heifers. 
Embryo Quality CON1 MM2 SEM3 P-value 
Quality 1, no. 2.11 3.38 0.85 0.32 
   Average Proportion of Flush4, % 38.66 56.98 12.56 0.30 
  Average Proportion of Transferrable5, % 89.29 76.96 7.64 0.31 
  Average Proportion of Freezable6, % 88.48 78.70 7.02 0.23 
Quality 2, no.  0.24 0.74 0.23 0.08 
   Average Proportion of Flush4, % 2.87 8.76 2.92 0.17 
   Average Proportion of Transferrable5, % 11.52 21.30 7.02 0.23 
  Average Proportion of Freezable6, % 11.52 21.30 7.02 0.23 
Quality 3, no. 0.00 0.25 0.11 0.15 
   Average Proportion of Flush4, % 0.00 8.75 4.37 0.20 
   Average Proportion of Transferrable5, % 0.00 10.42 6.17 0.29 
Quality 4, no. 2.22 1.88 0.92 0.79 
   Degenerate, no. 0.67 1.25 0.44 0.37 
         Average Proportion of Flush4, % 17.12 16.66 9.75 0.97 
   Nonfertilized, no. 1.56 0.63 0.65 0.34 
         Average Proportion of Flush, % 29.17 6.97 9.65 0.15 
   Average Proportion of Flush4, % 46.30 23.63 12.18 0.22 
1 Control (Saline) 
2 Multimin90 containing 60 mg/mL Zn, 10 mg/mL Mn, 5 mg/mL Se, and 15 mg/mL Cu 
3 n = 9 for MM; n = 8 for CON  
4 of total structures collected, the number of embryos in a given stage 
5 of total embryos graded Quality 1-3, proportion that were of given stage 
6 of total embryos graded Quality 1-2, proportion that were of given stage 
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Table 5. Effects of an injectable trace mineral supplement at initiation of superovulation protocol on embryo development in 
yearling dairy heifers. 
Developmental Stage CON1 MM2 SEM3 P-value 
Stage 3, no. 0.00 0.13 0.09 0.29 
   Average Proportion of Flush4, % -0.10 2.54 1.73 0.29 
Stage 4, no. 0.55 1.76 0.45 0.09 
   Average Proportion of Flush4, % 11.57 34.87 8.88 0.11 
   Average Proportion of Transferrable5, % 43.73 44.05 17.04 0.99 
   Average Proportion of Freezable6, % 44.05 46.13 16.97 0.93 
Stage 5, no. 0.56 1.13 0.33 0.26 
   Average Proportion of Flush4, % 6.48 17.97 4.50 0.11 
   Average Proportion of Transferrable5, % 13.67 24.05 6.39 0.31 
   Average Proportion of Freezable6, % 12.95 27.77 6.95 0.18 
Stage 6, no. 0.78 0.63 0.44 0.81 
   Average Proportion of Flush4, % 13.43 6.61 6.39 0.47 
   Average Proportion of Transferrable5, % 24.40 10.36 8.82 0.31 
   Average Proportion of Freezable6, % 24.40 10.36 8.82 0.31 
Stage 7, no. 0.78 0.63 0.44 0.81 
   Average Proportion of Flush4, % 9.72 1.92 4.69 0.27 
   Average Proportion of Transferrable5, % 15.93 4.80 6.98 0.30 
   Average Proportion of Freezable6, % 15.93 4.80 6.98 0.30 
Stage 8, no. 0.11 -0.01 0.09 0.34 
   Average Proportion of Flush4, % 1.41 -0.09 1.09 0.34 
   Average Proportion of Transferrable5, % 2.39 -0.04 1.54 0.31 
   Average Proportion of Freezable6, % 2.39 -0.04 1.54 0.31 
1 Control (Saline) 
2 Multimin90 containing 60 mg/mL Zn, 10 mg/mL Mn, 5 mg/mL Se, and 15 mg/mL Cu 
3 n = 9 for MM; n = 8 for CON  
4 of total structures collected, the number of embryos in a given stage 
5 of total embryos graded Quality 1-3, proportion that were of given stage 
6 of total embryos graded Quality 1-2, proportion that were of given stage 
 
  
 
 
  
 
